Business
Alnylam Pharmaceuticals Inc. and Isis Pharmaceuticals Inc. have formed a venture uniting Nobel Prize winners David Baltimore and Phillip Sharp to create drugs from a newly discovered class of genetic material.
Sept. 8, 2007
Science & Medicine
The Swiss drug maker is granted rights to gene-silencing technology from the Massachusetts firm.
July 10, 2007
For all the flak the pharmaceutical industry has taken for its exorbitant pricing practices, there’s no getting around the fact that it’s been a pretty stunning decade for medical progress.
Dec. 30, 2019
It is making a big bet on the tiny biotech firm and ‘RNA interference technology.’
Oct. 31, 2006
Money & Company
This article was originally on a blog post platform and may be missing photos, graphics or links.
July 23, 2008
Merger Suit Filed: Shareholders of Viratek Inc. and SPI Pharmaceuticals Inc. have filed two lawsuits in Delaware, where the companies are incorporated, seeking to block the companies’ proposed merger with ICN Pharmaceuticals Inc., which would create a $500-million company.
Aug. 5, 1994
Medicscript Inc., a pharmaceutical repackaging company based in Brea, has been acquired Summit Health Ltd., a Los Angeles-based health care company.
March 8, 1987
Orange County Inspirational Women Forum and Leadership Awards
Dianne Whitfield, chief human resources officer at Tarsus Pharmaceuticals, brings over 20 years of HR experience to her role.
Sept. 17, 2023
Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings.
July 18, 2014
The American and Toronto stock exchanges began two-way, international electronic trading in equity securities . . .
Sept. 25, 1985